Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The potential for stem cell therapy in diabetes.

Juris J Meier1, Anil Bhushan, Peter C Butler

  • 1Larry Hillblom Islet Research Center, University of California Los Angeles, David Geffen School of Medicine, 90095, USA.

Pediatric Research
|March 22, 2006
PubMed
Summary

Human embryonic stem cells offer a promising alternative for beta-cell replacement therapy in diabetes. Research focuses on generating and differentiating these stem cells to address the limitations of current diabetes treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structurally Diverse Secondary Metabolites from the Stem of <i>Tinospora cordifolia</i> and Their Anti-Inflammatory Potential on RAW264.7 Macrophages.

Journal of natural products·2026
Same author

Osteoprotegerin-Enabled Immune Evasion of Pathological Adipose Stromal Cells Drives Metabolic Dysfunction in Obesity.

bioRxiv : the preprint server for biology·2026
Same author

Design and synthesis of novel derivatives of bioactive sesquiterpenes Dehydrocostus lactone and Costunolide and their evaluation as leishmanicidal agents with an improved safety profile.

Bioorganic chemistry·2025
Same author

Selective membrane disrupting dispiro-oxindole Dehydrocostuslactone hybrids with potent anti-MRSA, antibiofilm, and synergistic activity.

Bioorganic chemistry·2025
Same author

Effect of Oral Semaglutide Versus Comparators on Multiple Cardiometabolic Risk Factor Control in Adults With Type 2 Diabetes.

Diabetes care·2025
Same author

Subcellular Compartmentalization of Glucose Mediated Insulin Secretion.

Cells·2025

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Endocrinology

Background:

  • Type 1 and type 2 diabetes are marked by insufficient insulin secretion due to beta-cell loss.
  • Current beta-cell replacement therapies like pancreas and islet transplantation are limited by donor organ scarcity.
  • Islet transplantation often results in progressive functional decline, necessitating a return to insulin therapy.

Purpose of the Study:

  • To review recent advancements in generating, culturing, and differentiating human embryonic stem (ES) cells.
  • To discuss the potential of human ES cells as a source for therapeutic beta-cells.
  • To address challenges associated with using human ES cells for diabetes treatment.

Main Methods:

  • Review of current literature on human embryonic stem cell generation and differentiation protocols.

Related Experiment Videos

  • Analysis of studies on beta-cell function post-transplantation.
  • Discussion of ethical and technical considerations for clinical application.

    • Main Results:

    • Significant progress has been made in generating and differentiating human ES cells into insulin-producing cells.
    • Human ES cells present a potentially scalable source for beta-cell replacement therapy.
    • Challenges remain in achieving long-term functional stability and immune compatibility.

    Conclusions:

    • Human embryonic stem cells hold considerable promise for developing novel diabetes therapies.
    • Further research is crucial to overcome barriers to clinical translation.
    • ES cell-derived beta-cells could revolutionize diabetes management by offering a renewable source for cell replacement.